MRI Measure May ID Men at Risk for Postradiation Genitourinary Toxicity
FRIDAY, Dec. 1, 2023 -- Longer prostatic urethral length measured on prostate magnetic resonance imaging (MRI) is independently associated with a higher risk for developing late genitourinary (GU) toxicity after radiation therapy (RT) for prostate... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 1, 2023 Category: Pharmaceuticals Source Type: news
GE HealthCare to showcase AI technology at RSNA
GE HealthCare (GEHC) said it will highlight the company’s AI technology at RSNA 2023, and noted a focus on putting unused healthcare data to use to help providers optimize care.
Approximately 30% of the world’s data is generated by healthcare and 97% of data produced by hospitals remains unused, GE HealthCare said. In addition, the pace of digitization has quickened over the past three years, in part due to the COVID-19 pandemic, the company said.
At RSNA, the company will showcase its App Orchestrator, an application orchestration solution that can give customers easy access to multiple applications from multiple c...
Source: AuntMinnie.com Headlines - November 22, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
RaySearch Laboratories posts increased revenues in Q3
Swedish radiation therapy company RaySearch Laboratories has posted third-quarter and nine-month revenue increases (end-September 30).Net sales for the quarter were 252.9 million Swedish krona ($24 million U.S.), compared with 210.8 million krona ($20 million) last year. Net sales for the nine-month period were 722.5 million krona ($68.6 million), compared with 579.3 million krona ($55 million) in 2022.For the quarter, profit after tax was 21.6 million krona ($2 million); for the nine months, the company reported profit after tax of 50 million krona ($4.8 million), up from 9.6 million krona ($911,440) for the same perio...
Source: AuntMinnie.com Headlines - November 20, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Hospitals serving large Black, Latino populations have fewer resources for cancer care
Key takeawaysUCLA researchers looked at nearly 4,400 hospitals across the U.S., including 864 with high numbers of Black and Hispanic patients.Hospitals serving Black, Hispanic and other racial and ethnic minority patients were significantly less likely than other hospitals to have access to core cancer services like PET/CT scanners, robotic surgery and palliative care.The researchers say further work is need to understand how geographic, linguistic, cultural, cost and discrimination factors affect these cancer care disparities. Among the nation ’s hospitals, those that serve high numbers of Black and Hispanic patients...
Source: UCLA Newsroom: Health Sciences - November 16, 2023 Category: Universities & Medical Training Source Type: news
Mevion wins Fla. install of proton therapy system
Mevion Medical Systems has won a contract to install its Mevion S250-FIT proton therapy system at a Florida radiation therapy center.BayCare healthcare system will install the system in Fall 2025 at the Fred J. Woods Radiation Therapy Center at St. Joseph’s Hospital in Tampa.Mevion S250-FIT features Hyperscan pencil beam scanning for intensity-modulated proton therapy and can support technologies such as ARC therapy, adaptive planning, dual-energy CT, and FLASH therapy, according to Mevion.The system is not yet available for clinical use, the company noted. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 3, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
PD-1 Inhibitor Improves Outcomes in NHL Subtype PD-1 Inhibitor Improves Outcomes in NHL Subtype
Treatment with the PD-1 inhibitor toripalimab plus radiation therapy improved outcomes in patients with a subtype of non-Hodgkin lymphoma, new data show.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Ocular MALT Lymphoma: Radiation Reduces Relapse Ocular MALT Lymphoma: Radiation Reduces Relapse
While relapse is common among patients with this type of lymphoma, those rates decline significantly with the addition of radiation therapy.MDedge News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 30, 2023 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Is Short-Term ADT Good Enough in High-Risk Prostate Cancer? Is Short-Term ADT Good Enough in High-Risk Prostate Cancer?
Continuing ADT beyond 6 months does not improve outcomes in men with high-risk localized prostate cancer also receiving brachytherapy and external beam radiation therapy, new research suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 17, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
' Reassuring' Data on Partial-Breast Radiation in Early BC'Reassuring' Data on Partial-Breast Radiation in Early BC
A 10-year follow-up analysis found that partial-breast and reduced-dose radiation therapy were noninferior to full-breast radiation therapy among women with early breast cancer.MDedge News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 9, 2023 Category: Radiology Tags: Hematology-Oncology News Source Type: news
' Liquid Biopsy' Could Help Guide Lung Cancer Treatment
MONDAY, Oct. 9, 2023 -- For a subset of patients with advanced lung cancer, radiation therapy can sometimes substantially extend their lives.
Now a new study hints that a blood test could be used to identify the people most likely to benefit.
Right... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 9, 2023 Category: General Medicine Source Type: news
Reducing Cognitive Impairment From SCLC Brain Metastases Reducing Cognitive Impairment From SCLC Brain Metastases
Stereotactic radiosurgery was better at preventing loss of verbal recall function at 3 months than whole-brain radiation therapy, the current standard of care for patients with brain metastases from small cell lung cancer.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 4, 2023 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Short-Course SBRT: Standard of Care in Prostate Cancer? Short-Course SBRT: Standard of Care in Prostate Cancer?
For patients with low and favorable intermediate-risk prostate cancer, stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam radiation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Shorter Course of Radiation May Be Safe for Women Undergoing Breast Reconstruction
WEDNESDAY, Oct. 4, 2023 -- Breast cancer patients who undergo a mastectomy can probably benefit from a shorter course of more intense radiation therapy, a new study indicates.
Hypofractionated radiation therapy — which provides a higher dose each... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 4, 2023 Category: General Medicine Source Type: news
Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RT
(MedPage Today) -- SAN DIEGO -- Hypofractionated radiation appeared to be as safe and effective as conventionally fractionated radiation therapy for patients with breast cancer who underwent implant-based breast reconstruction following mastectomy... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 4, 2023 Category: Hematology Source Type: news
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer
(MedPage Today) -- SAN DIEGO -- Stereotactic body radiation therapy (SBRT) was as effective as conventional radiation therapy (CRT) in treating intermediate-risk prostate cancer, according to results from the randomized PACE-B trial.
Among 874... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 3, 2023 Category: Hematology Source Type: news
